Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nils Vollmar"'
Autor:
Philipp Fervers, Jonathan Kottlors, Nils Große Hokamp, Johannes Bremm, David Maintz, Stephanie Tritt, Orkhan Safarov, Thorsten Persigehl, Nils Vollmar, Paul Martin Bansmann, Nuran Abdullayev
Publikováno v:
PLoS ONE, Vol 16, Iss 7, p e0255045 (2021)
PurposeCardiovascular comorbidity anticipates severe progression of COVID-19 and becomes evident by coronary artery calcification (CAC) on low-dose chest computed tomography (LDCT). The purpose of this study was to predict a patient's obligation of i
Externí odkaz:
https://doaj.org/article/0982504afb134978b21aac7ebd580176
Autor:
Susanne Tan, Nils Vollmar, Sven Benson, Jan-Peter Sowa, Lars P. Bechmann, Guido Gerken, Dagmar Fuhrer, Ali Canbay
Publikováno v:
International Journal of Endocrinology, Vol 2015 (2015)
Objective. Polycystic ovary syndrome (PCOS) is associated with obesity and insulin resistance (IR), key features of nonalcoholic steatohepatitis (NASH). Cytokeratin 18 fragments (M30) have been established as a serum marker for NASH. The insulin sens
Externí odkaz:
https://doaj.org/article/656ef10b899547cea460145715a3a405
Autor:
Philipp Harter, Pier Francesco Alesina, Andreas du Bois, Stephanie Schneider, Jens Albrecht Koch, Sonia Prader, Mareike Bommert, Kai-Uwe Waltering, Alexander Traut, Beyhan Ataseven, Nils Vollmar, Sebastian Heikaus, Florian Heitz
Publikováno v:
Gynecologic Oncology. 152:76-81
Background Cardiophrenic lymph nodes (CPLN) define FIGO stage IVB disease. We evaluate the pattern of CPLN metastases, their prognostic impact and the potential role of CPLN resection in patients with epithelial ovarian cancer (EOC). Methods Analysis
Autor:
Nils Vollmar, Jan-Peter Sowa, Sven Benson, Ali Canbay, Susanne Tan, Guido Gerken, Lars P. Bechmann, Dagmar Führer
Publikováno v:
International Journal of Endocrinology, Vol 2015 (2015)
International Journal of Endocrinology
International Journal of Endocrinology
Objective. Polycystic ovary syndrome (PCOS) is associated with obesity and insulin resistance (IR), key features of nonalcoholic steatohepatitis (NASH). Cytokeratin 18 fragments (M30) have been established as a serum marker for NASH. The insulin sens